ENvue Medical Launches Vibration Tech for Nasogastric Tube Comfort – A new program using vibration technology aims to alleviate discomfort from nasogastric tubes
Thursday, January 29, 2026 BiopharmaWatch Research 1 min read
Key Takeaway: ENvue Medical, Inc. has launched a program utilizing vibration technology from its NanoVibronix division to enhance comfort for patients with nasogastric tubes. This initiative aims to alleviate the discomfort often experienced with these tubes, which are essential in hospital settings. The program is supported by clinical research showing that micro-vibration can reduce friction at the tube-tissue interface.
Price reaction · baseline $2.3 (2026-01-28 close) · hit pre-market · 1 other FEED headline(s) in the window, move may be shared
day 0 close · peak
+67%
day 1
+40.4%
day 3
+7%
Market Sentiment Analysis
POSITIVE FACTORS
Launch of innovative vibration technology to improve patient comfort.
Addresses a common issue with nasogastric tubes that has limited solutions.
Backed by peer-reviewed clinical research demonstrating effectiveness.
Full Press Release Details
ENvue Medical, Inc. announced the launch of a development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes.
Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwelling NG tubes are commonly associated with nasal and throat discomfort during the dwell phase, an issue for which limited mitigation options currently exist.
The program builds on previously published, peer-reviewed clinical research demonstrating that surface acoustic wave micro-vibration technology applied to nasogastric tubes can reduce friction at the tube–tissue interface during indwelling use.